Status:
ACTIVE_NOT_RECRUITING
Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
University of Cincinnati
Good Samaritan Hospital, Ohio
Conditions:
Premature Infant
Eligibility:
All Genders
Up to 3 years
Brief Summary
The Early Prediction Study is a longitudinal population-based cohort study for very preterm infants ≤32 weeks gestational age. Preterm infants recruited from three greater Cincinnati and two Dayton ar...
Detailed Description
With every neonatal intensive care unit discharge, physicians and early intervention specialists face a critical challenge: How to counsel parents about their very preterm infant's risk of developing ...
Eligibility Criteria
Inclusion
- Hospitalized infants born at ≤32 weeks completed gestational age that are being cared for in all three level III/IV NICUs from the Greater Cincinnati area.
Exclusion
- Infants with known chromosomal or congenital anomalies affecting the central nervous system or with cyanotic heart disease.
Key Trial Info
Start Date :
September 16 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2027
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT03345069
Start Date
September 16 2016
End Date
November 1 2027
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229